Last updated on February 2019

A Randomized Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients


Brief description of study

The purpose of this study is to demonstrate the superiority of LCZ696 over individualized medical therapy for comorbidities in reducing N-terminal pro-brain natriuretic peptide (NT-proBNP) and improving HF symptoms and functional capacity in patients with heart failure with preserved ejection fraction (HFpEF).

Clinical Study Identifier: NCT03066804

Find a site near you

Start Over

Novartis Investigative Site

Phoenix, AZ United States
  Connect »

Novartis Investigative Site

Beverly Hills, CA United States
  Connect »

Novartis Investigative Site

Long Beach, CA United States
  Connect »

Novartis Investigative Site

Northridge, CA United States
  Connect »

Novartis Investigative Site

Stamford, CT United States
  Connect »

Novartis Investigative Site

Bradenton, FL United States
  Connect »

Novartis Investigative Site

Arlington Heights, IL United States
  Connect »

Novartis Investigative Site

New Orleans, LA United States
  Connect »

Novartis Investigative Site

Lincoln, NE United States
  Connect »

Novartis Investigative Site

Las Vegas, NV United States
  Connect »

Novartis Investigative Site

Potsdam, NY United States
  Connect »

Novartis Investigative Site

Rochester, NY United States
  Connect »

Novartis Investigative Site

Corvallis, OR United States
  Connect »

Novartis Investigative Site

Abington, PA United States
  Connect »

Novartis Investigative Site

Tomball, TX United States
  Connect »

Novartis Investigative Site

Falls Church, VA United States
  Connect »

Novartis Investigative Site

Everett, WA United States
  Connect »

Novartis Investigative Site

Seattle, WA United States
  Connect »

Novartis Investigative Site

Spokane, WA United States
  Connect »

Novartis Investigative Site

San Miguel de Tucuman, Argentina
  Connect »

Novartis Investigative Site

Chambray les Tours, France
  Connect »

Novartis Investigative Site

Moldava nad Bodvou, Slovakia
  Connect »

Novartis Investigative Site

Povazska Bystrica, Slovakia
  Connect »

Novartis Investigative Site

San Sebastian de los Reyes, Spain
  Connect »

Novartis Investigative Site

Las Palmas De Gran Canarias, Spain
  Connect »

Novartis Investigative Site

High Wycombe, United Kingdom
  Connect »

Novartis Investigative Site

Addlestone, United Kingdom
  Connect »

Novartis Investigative Site

Sunderland, United Kingdom
  Connect »

Novartis Investigative Site

Delray Beach, FL United States
  Connect »

Novartis Investigative Site

Gainesville, FL United States
  Connect »

Novartis Investigative Site

Kansas City, KS United States
  Connect »

Novartis Investigative Site

Hattiesburg, MS United States
  Connect »

Novartis Investigative Site

Kettering, OH United States
  Connect »

Novartis Investigative Site

Sioux Falls, SD United States
  Connect »

Novartis Investigative Site

Ciudad de Salta, Argentina
  Connect »

Novartis Investigative Site

Sao Jose do Rio Preto, Brazil
  Connect »

Novartis Investigative Site

Roznov pod Radhostem, Czechia
  Connect »

Novartis Investigative Site

Valasske Mezirici, Czechia
  Connect »

Novartis Investigative Site

Le Kremlin Bicetre, France
  Connect »

Novartis Investigative Site

Rotenburg an der Fulda, Germany
  Connect »

Novartis Investigative Site

Schwaebisch Hall, Germany
  Connect »

Novartis Investigative Site

Guatemala City, Guatemala
  Connect »

Novartis Investigative Site

Sesto San Giovanni, Italy
  Connect »

Novartis Investigative Site

San Vito al Tagliamento, Italy
  Connect »

Novartis Investigative Site

Viana do Castelo, Portugal
  Connect »

Novartis Investigative Site

Ekaterinburg, Russian Federation
  Connect »

Novartis Investigative Site

Gatchina, Russian Federation
  Connect »

Novartis Investigative Site

Ivanovo, Russian Federation
  Connect »

Novartis Investigative Site

Moscow, Russian Federation
  Connect »

Novartis Investigative Site

Nizhnii Novgorod, Russian Federation
  Connect »

Novartis Investigative Site

Saint Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Saint-Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Saratov, Russian Federation
  Connect »

Novartis Investigative Site

St Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Tyumen, Russian Federation
  Connect »

Novartis Investigative Site

Yaroslavl, Russian Federation
  Connect »

Novartis Investigative Site

Yekaterinburg, Russian Federation
  Connect »

Novartis Investigative Site

Banska Bystrica, Slovakia
  Connect »

Novartis Investigative Site

Torrevieja (Alicante), Spain
  Connect »

Novartis Investigative Site

Stockton on Tees, United Kingdom
  Connect »

Novartis Investigative Site

Chesterfield, United Kingdom
  Connect »

Novartis Investigative Site

Craigavon, United Kingdom
  Connect »

Novartis Investigative Site

Bochum Wattenscheid, Germany
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.